Invention Grant
US07794734B2 Mannheimia haemolytica chimeric outer membrane protein PlpE and leukotoxin epitopes as a vaccine or vaccine component against shipping fever
有权
溶血性溶血性血友病病毒（Mannheimia haemolytica）嵌合外膜蛋白质PlpE和白细胞抗原表位作为针对发热的疫苗或疫苗组分
- Patent Title: Mannheimia haemolytica chimeric outer membrane protein PlpE and leukotoxin epitopes as a vaccine or vaccine component against shipping fever
- Patent Title (中): 溶血性溶血性血友病病毒（Mannheimia haemolytica）嵌合外膜蛋白质PlpE和白细胞抗原表位作为针对发热的疫苗或疫苗组分
-
Application No.: US11545069Application Date: 2006-10-06
-
Publication No.: US07794734B2Publication Date: 2010-09-14
- Inventor: Sahlu Ayalew , Anthony W. Confer
- Applicant: Sahlu Ayalew , Anthony W. Confer
- Applicant Address: US OK Stillwater
- Assignee: The Board of Regents for Oklahoma State University
- Current Assignee: The Board of Regents for Oklahoma State University
- Current Assignee Address: US OK Stillwater
- Agency: Fellers, Snider, Blankenship, Bailey & Tippens
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/102 ; A61K39/02 ; A61K39/38 ; A61K39/116 ; A61K38/00 ; C07K14/00
Abstract:
Vaccine preparations for the prevention and treatment of bovine respiratory disease (BRD) and, in particular, its most severe form, termed “shipping fever”, are provided. The preparations comprise chimeric proteins comprising immunodominant epitopes of recombinant Mannheimia haemolytica outer membrane protein PlpE, and immunodominant epitopes of recombinant M. haemolytica leukotoxin.
Public/Granted literature
Information query
